219 related articles for article (PubMed ID: 24863191)
1. Mesoporous carbon with spherical pores as a carrier for celecoxib with needle-like crystallinity: improve dissolution rate and bioavailability.
Zhu W; Zhao Q; Sun C; Zhang Z; Jiang T; Sun J; Li Y; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():13-20. PubMed ID: 24863191
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of celecoxib into fibrous ordered mesoporous carbon for enhanced oral bioavailability and reduced gastric irritancy.
Zhao P; Jiang H; Jiang T; Zhi Z; Wu C; Sun C; Zhang J; Wang S
Eur J Pharm Sci; 2012 Apr; 45(5):639-47. PubMed ID: 22251657
[TBL] [Abstract][Full Text] [Related]
3. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability.
Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S
Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621
[TBL] [Abstract][Full Text] [Related]
5. A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib.
Zhang Y; Wang H; Li C; Sun B; Wang Y; Wang S; Gao C
Pharm Res; 2014 Apr; 31(4):1059-70. PubMed ID: 24287624
[TBL] [Abstract][Full Text] [Related]
6. The mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier.
Wang T; Zhao P; Zhao Q; Wang B; Wang S
Drug Deliv; 2016; 23(2):420-8. PubMed ID: 24870199
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Evaluation of Core-Shell Mesoporous Silica as a Promising Water-Insoluble Drug Delivery System: Improving the Dissolution Rate and Bioavailability of Celecoxib With Needle-Like Crystallinity.
Han C; Zhang S; Huang H; Dong Y; Sui X; Jian B; Zhu W
J Pharm Sci; 2019 Oct; 108(10):3225-3232. PubMed ID: 31226426
[TBL] [Abstract][Full Text] [Related]
8. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
9. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
Tan A; Simovic S; Davey AK; Rades T; Prestidge CA
J Control Release; 2009 Feb; 134(1):62-70. PubMed ID: 19013488
[TBL] [Abstract][Full Text] [Related]
10. Increasing the dissolution rate and oral bioavailability of the poorly water-soluble drug valsartan using novel hierarchical porous carbon monoliths.
Zhang Y; Che E; Zhang M; Sun B; Gao J; Han J; Song Y
Int J Pharm; 2014 Oct; 473(1-2):375-83. PubMed ID: 25051114
[TBL] [Abstract][Full Text] [Related]
11. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib.
Riikonen J; Correia A; Kovalainen M; Näkki S; Lehtonen M; Leppänen J; Rantanen J; Xu W; Araújo F; Hirvonen J; Järvinen K; Santos HA; Lehto VP
Biomaterials; 2015 Jun; 52():44-55. PubMed ID: 25818412
[TBL] [Abstract][Full Text] [Related]
12. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
13. Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.
Zhang Y; Wang H; Gao C; Li X; Li L
Eur J Pharm Sci; 2013 Aug; 49(5):864-72. PubMed ID: 23791638
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances.
Forsgren J; Andersson M; Nilsson P; Mihranyan A
Adv Healthc Mater; 2013 Nov; 2(11):1469-76. PubMed ID: 23703752
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
16. Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.
Bai A; Wu C; Liu X; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y
Drug Des Devel Ther; 2018; 12():2129-2138. PubMed ID: 30022811
[TBL] [Abstract][Full Text] [Related]
17. Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluation.
Nguyen TH; Tan A; Santos L; Ngo D; Edwards GA; Porter CJ; Prestidge CA; Boyd BJ
J Control Release; 2013 Apr; 167(1):85-91. PubMed ID: 23353808
[TBL] [Abstract][Full Text] [Related]
18. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.
Tan A; Davey AK; Prestidge CA
Pharm Res; 2011 Sep; 28(9):2273-87. PubMed ID: 21560021
[TBL] [Abstract][Full Text] [Related]
19. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
20. A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.
Han C; Huang H; Dong Y; Sui X; Jian B; Zhu W
Molecules; 2019 May; 24(9):. PubMed ID: 31067732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
